Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial

Simple item page
dc.contributor.authorBiswal, S.
dc.contributor.authorBorja-Tabora, C.
dc.contributor.authorVargas, L.M.
dc.contributor.authorFernando, A.D.
dc.contributor.authorGunasekera, D.
dc.date.accessioned2022-09-15T08:54:17Z
dc.date.available2022-09-15T08:54:17Z
dc.date.issued2020
dc.identifier.citationBiswal, S., et al. (2020). Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial. www.thelancet.com Vol 395 May 2, 2020.en_US
dc.identifier.urihttp://dr.lib.sjp.ac.lk/handle/123456789/12304
dc.language.isoenen_US
dc.titleEfficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trialen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Efficacy of a tetravalent dengue vaccine in healthy children.pdf
Size:
496.52 KB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

2020 - Medical